Search results
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 2 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 2 days agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 2 days agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 2 days agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Albert Bourla
Time Magazine· 1 day agoWhen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. “No...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 2 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
What's Going With Pfizer Stock On Wednesday? - Pfizer (NYSE:PFE)
Benzinga· 2 days agoOn Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year,...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 2 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer reports dip in first quarter profits, yet beats estimates
dpa international via Yahoo Finance· 2 days agoThe US pharmaceutical giant Pfizer on Wednesday said its earnings for the first quarter had declined...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 4 days agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
